Iovance Biotherapeutics, Inc. · NASDAQ:IOVA

Puri Raj K. exercised options for 5,470 Iovance Biotherapeutics, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 3, 2026

On Sep 1, 2026, Puri Raj K. (Chief Regulatory Officer) exercised options for 5,470 Iovance Biotherapeutics, Inc. shares, leaving 251,076 shares. Filed Sep 3, 2026 (Form 4).

Options exercised
5,470 shares
Holding after
251,076 shares
Trading plan
No
Role
Chief Regulatory Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockOption exercise5,470253,584Direct
Sep 1, 2026Common StockShares withheld for tax2,508US$8.28251,076Direct

Source

View original at SEC

Related